News | Proton Therapy | July 29, 2015

Willis-Knighton Cancer Center Approaches First Anniversary With IBA’s Proteus One System

Cancer teams able to treat up to 20 patients per day with compact intensity modulated proton therapy system

IBA, Proteus One, compact proton therapy system, Willis-Knighton Cancer Center

July 29, 2015 — Teams at the Willis-Knighton Cancer Center in Shreveport, Louisiana, have achieved high levels of quality care, ease of use and speed of treatment in 11 months on IBA’s Proteus One compact proton therapy system.

After a record-setting 11 month installation with patient treatment beginning in September 2014, the Willis-Knighton team continues to set new records by employing a compact proton therapy system that treats clinically with pencil beam scanning (PBS). In addition to treating more common indications such as the brain and prostate, PBS has accelerated their ramp speed by enabling new applications such as breast, head and neck, esophageal lung, spine cancer, pediatric malignancies and various pelvis indications.

By working together with IBA, the Willis Knighton team is currently averaging 15 minutes per patient for most indications, even with multiple fields, resulting in a daily volume of 20 patients per eight-hour day. They expect that volume to increase based upon the even faster treatment times and expanded applications that Advanced Image Guidance with cone beam computed tomography (CBCT) will bring them. IBA’s Cone Beam CT is the only volumetric imaging solution to have obtained marketing authorization by the U.S. Food and Drug Administration (FDA) and is in clinical use daily.

Lane R. Rosen, M.D., director of radiation oncology at the Willis-Knighton Cancer Center, added: “The Proteus One has exceeded all of our expectations. We are very excited to have intensity modulated proton therapy and cone beam CT imaging available for our patients. Both Willis-Knighton and IBA teams have been partnering at each step to ensure a smooth transition from installation to first treatment and beyond during the ramp-up of operations. We have met or exceeded all of our expectations with this collaboration and are looking forward to even more treatment options for our patients in the future"

For more information:

Related Content

News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
Mercy Signs Multi-System, Multi-Hospital Agreement for Accuray Radiotherapy Systems
News | Radiation Therapy | May 16, 2018
Accuray Inc. signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact and...
ViewRay Unveils New Soft Tissue Visualization Technologies for MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | April 30, 2018
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.
Technology | Quality Assurance (QA) | April 27, 2018
Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality...
RayStation Users Win Inaugural Treatment Planning World Championships
News | Treatment Planning | April 27, 2018
In the first World Championships of Treatment Planning, arranged by radiation oncology analytics company ProKnow and...
Brainlab Introduces New Hi-Res Planning Algorithm for VersaHD
News | Treatment Planning | April 24, 2018
Brainlab announced the implementation of a software solution that can achieve better radiation dose conformity around...
Shorter Radiotherapy Courses Safe and Effective for Prostate Cancer
News | Prostate Cancer | April 23, 2018
Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate cancer patients,...
Elekta Expands Mosaiq Oncology Information System With PalabraApps
News | Oncology Information Management Systems (OIMS) | April 20, 2018
April 20, 2018 — Elekta announced that it is making a strategic investment in PalabraApps LLC to advance the developm
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Overlay Init